AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

United States Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry Report 2021 - ResearchAndMarkets.com

June 24, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Jun 24, 2021--

The “Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2027, NAIC 325414” report from Plunkett Research Ltd has been added to ResearchAndMarkets.com’s offering.

Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research.

Key Findings

  • Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.) to reach $60,076,918,645 million by 2027.
  • Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry, including Average EBITDA, Operating Ratios and Sales per Employee.

ADVERTISEMENT

Core Benefits to Customer

1) Comprehensive overview of an industry’s financial results, ratios, vital statistics and metrics in one package

2) Complete benchmarking of the industry and its top companies

3) Deep industry and company financials

This Report Features

1) Historical data

2) Revenue forecasts, growth rates and CAGR

3) Operating ratios

4) Complete data for benchmarking a company to its industry and to specific leading companies

5) Benchmarking this industry to all U.S. industries

6) Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies

Key Data

Industry Summary

  • Revenues historical through 2020
  • Revenues projected through 2027
  • Employee Count 2012-2019
  • Annual Growth Rate 2020
  • CAGR 2012 through 2020
  • CAGR 2021 through 2027
  • Top U.S. Companies

Employment and Establishments

  • Number of Firms 2012-2019
  • Number of Establishments 2012-2019
  • Employees, 2012-2019
  • Average Annual Sales per Firm & per Establishment 2012-2019
  • Sales per Employee

Average Annual Operating Ratios

  • Revenue Compared to All Industries
  • Expenses Compared to All Industries
  • Profits & Income Taxes Compared to All Industries

Benchmarks

This Industry Compared to All Industries

  • Comparison of Revenues, Profits and Taxes to All Industries

Industry Results, Publicly-Held Companies (U.S.), Average for all Companies

  • Industry Income Statement, Balance Sheet, Cash Flow Statement, 2012-2019

Top Companies Profiled & Ranked

ADVERTISEMENT

  • In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations

Top Companies Ranked

  • Market Capitalization
  • Employees
  • Revenue
  • Net Income
  • 3-Year Revenue Growth
  • 3-Year Income Growth
  • Return on Assets
  • Return on Equity
  • Return on Invested Capital

List of Leading (Public and Private) Companies

  • Comparison of Individual Top Publicly-Held Companies to Industry Averages, 2019
  • Income Statements, Balance Sheets and Cash Flow Stat

Companies Mentioned

  • CSL Behring LLC
  • DuPont Nutrition & Biosciences
  • Emergent BioSolutions Inc
  • Forever Living Products International Inc
  • Halozyme Therapeutics Inc
  • Janssen Pharmaceuticals Inc
  • MiMedx Group Inc
  • Organogenesis Inc
  • RTI Surgical Inc
  • Zoetis Inc

For more information about this report visit https://www.researchandmarkets.com/r/hi6apn

View source version on businesswire.com:https://www.businesswire.com/news/home/20210624005842/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH SURGERY

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 06/24/2021 12:19 PM/DISC: 06/24/2021 12:19 PM

http://www.businesswire.com/news/home/20210624005842/en